Patel Neil D, Levi Daniel S, Cheatham John P, Qureshi Shakeel A, Shahanavaz Shabana, Zahn Evan M
Children's Hospital Los Angeles, Los Angeles, California.
Mattel Children's Hospital at The University of California, Los Angeles, Los Angeles, California.
J Soc Cardiovasc Angiogr Interv. 2022 Sep 16;1(6):100452. doi: 10.1016/j.jscai.2022.100452. eCollection 2022 Nov-Dec.
Transcatheter pulmonary valve replacement was first performed by Dr Philip Bonhoeffer, who implanted a Medtronic Melody valve in a human in 2000. Over the past 2 decades, there have been many advances in transcatheter pulmonary valve technology. This includes the use of the SAPIEN transcatheter heart valve in the pulmonary position, modifications and refinements to valve implantation procedures, and development of self-expanding valves and prestents to treat large diameter native or patched right ventricular outflow tracts. This article reviews the current transcatheter pulmonary valve technologies with a focus on valve design, screening process, implant procedure, and clinical outcomes.
经导管肺动脉瓣置换术最早由菲利普·邦霍费尔医生实施，他于2000年在人体中植入了美敦力公司的旋律瓣膜。在过去的20年里，经导管肺动脉瓣技术取得了许多进展。这包括在肺动脉位置使用爱德华 Sapien 经导管心脏瓣膜、对瓣膜植入程序的改进和完善，以及开发用于治疗大直径天然或补片右心室流出道的自膨胀瓣膜和预扩张支架。本文回顾了当前的经导管肺动脉瓣技术，重点关注瓣膜设计、筛选过程、植入程序和临床结果。
